Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
Condition: Alpha1-Antitrypsin Deficiency Interventions: Drug: Fazirsiran Injection; Other: Placebo Sponsors: Takeda; Takeda Development Center Americas, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alpha-1 Antitrypsin Deficiency | Learning | Liver | Liver Disease | Research | Study | Universities & Medical Training | Urology & Nephrology